Company intelligence
Cytiva
We envision a world in which access to life-changing therapies transforms human health.
About Cytiva
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We're the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman. We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health. Visit https://www.cytiva.com/privacy to review our privacy policy.
Verified activity
Signals from Cytiva
51 published signals
Products & Services
Cytiva introduced process-specific filter validation services designed to support low and ultra-low product volumes.
Reported by Valentin Rüttimann
Presence & Recognition
Cytiva completed Day 3 of the Exmouth to Newquay challenge, covering 156.7 km and 2,350 m of climbing.
Reported by Paul Chapman
Products & Services
Cytiva introduced HyClone boost expression supplements designed to support transient transfection workflows and increase recombinant protein and rAAV production.
Reported by Wade Fischer
Presence & Recognition
Cytiva is hosting a webinar on 15th September exploring automation, parallel chromatography, and smart software features to increase throughput and maintain purification performance.
Reported by Mark Frost, PhD
Presence & Recognition
Cytiva is hosting a discussion at PRIME: Development by design featuring scientists to discuss early decisions on developability, scalability, and manufacturing readiness.
Reported by Josmary Medrano
Research & Knowledge
Cytiva published an application note showing how inline concentration can reduce pool volumes, achieving approximately 3x concentration with high product recovery under the conditions evaluated.
Reported by Sarah Potez
Products & Services
Cytiva introduced the NxGen scale-ready cartridge 12 L/h, designed with GMP in mind, to help maintain the same LNP workflow on the NanoAssemblr Ignite+ system as your program advances.
Reported by Sarah Potez
Presence & Recognition
Cytiva is hosting an event in Chicago, October 13, featuring product demonstrations and expert-led sessions for bioprocessing professionals.
Reported by Sara Liliensiek, PhD
Research & Knowledge
Cytiva developed the HyClone glycan supplement to increase galactosylation while maintaining cell growth, viability, and titer across multiple CHO cell lines.
Reported by Thomas Falkman
Products & Services
Cytiva is enabling low-volume processing for gene therapies and MAbs through process-specific filter validation services designed to support low and ultra-low product volumes.
Reported by Darren Small
Presence & Recognition
Cytiva supported a webinar exploring practical approaches to smarter, more efficient protein purification workflows.
Reported by Laura DEMONT
Research & Knowledge
Cytiva published an evaluation showing inline concentration delivered >3x concentration and 97% product recovery, creating smaller pool volumes and the potential to shorten subsequent chromatography loading times.
Reported by Richard Carpenter
Presence & Recognition
Cytiva is hosting a webinar titled Blot Like a Boss: Mastering Western Blotting on September 16th at 5:00 PM CEST, 4:00 PM BST, 11:00 AM EDT, and 8:00 AM PDT.
Reported by Isabelle Westerlund, PhD.
Research & Knowledge
Cytiva has trusted Cell Boost in the production of five FDA-approved molecules.
Reported by Dirk Sievers
Research & Knowledge
Cytiva published an insight by Martin Ball exploring the shift from reacting to failures to predicting them using connected equipment, data, and AI.
Reported by Nicolas Pivet
Presence & Recognition
Cytiva hosted a global conference at the Nanomedicine Center in Vancouver to advance mRNA-based therapies and invivoCAR.
Reported by Andrew Yang, MBA
Research & Knowledge
Cytiva published an article in Hindustan Times by Uma Sinha Datta and Goutam Bhattacharya exploring how industry, academia, and policymakers can work together to build the workforce for advanced biologics, digital bioprocessing, regulatory science, and next-generation therapies.
Reported by Rajesh V.
Research & Knowledge
Cytiva published an evaluation showing inline concentration delivered >3x concentration and 97% product recovery, creating smaller pool volumes and the potential to shorten subsequent chromatography loading times.
Reported by Valentin Rüttimann
Presence & Recognition
Cytiva co-organizes the SR-TIGET 30 Years Symposium in Milan this November alongside Danaher colleagues and SR-TIGET.
Reported by Jeff Hinchman
Research & Knowledge
Cytiva published its 2025 Impact Report, which highlights higher productivity with lower carbon intensity and circular approaches that reduce waste without compromising performance.
Reported by Valerie Marjollet
Presence & Recognition
Cytiva participated to the 3rd Innovation Day of Bilfinger Life Science at Toussieu, France.
Reported by Laura DEMONT
Products & Services
Cytiva introduced the NxGen scale-ready cartridge 12 L/h, designed with GMP in mind, to help maintain the same LNP workflow on the NanoAssemblr Ignite+ system as your program advances.
Reported by Rajesh V.
Research & Knowledge
Cytiva published research showing that inline concentration can reduce pool volumes by approximately 3x concentration with high product recovery under evaluated conditions.
Reported by Sharon Vivian
Presence & Recognition
Cytiva is hosting a webinar titled Rethinking protein purification featuring Mark Frost from Cytiva on parallel chromatography and automation.
Reported by Sharon Vivian